A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature

Annals of Diagnostic Pathology

Volumn 5, Issue 3, 2001, Pages 129-140

  Paal, Edina ^a   Thompson, Lester D R ^a   Frommelt, R Allen ^a   Przygodzki, Ronald M ^a   Heffess, Clara S ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Anaplastic carcinoma; Giant cell carcinoma; Pancreas; Prognosis

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ANAPLASTIC CARCINOMA; ARMY; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SIZE; CLINICAL ARTICLE; FATIGUE; FEMALE; FOLLOW UP; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MEDICAL LITERATURE; NAUSEA; ONCOGENE K RAS; PANCREAS CARCINOMA; PRIORITY JOURNAL; PUBLICATION; SYMPTOM; UNITED STATES; VOMITING; WEIGHT REDUCTION;

EID: 0034938947     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1053/adpa.2001.25404     Document Type: Article

References (82)

1. Morphological study of 391 cases of exocrine pancreatic tumours with special reference to the classification of exocrine pancreatic carcinoma
2. Morphological patterns of primary nonendocrine human pancreas carcinoma
3. Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases
4. The pattern of pancreatic carcinoma at Kenyatta National Hospital
5. Pleomorphic carcinoma of the pancreas. An analysis of 15 cases
6. Pleomorphic carcinoma of the pancreas: Computed-tomographic, sonographic, and pathologic findings
7. The histologic spectrum, prognosis, and histogenesis of the sarcomatoid carcinoma of the pancreas
8. Histological typing of pancreatic and periampullary carcinoma
9. Use of Avidin-Biotin-Peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
10. Modified antigen retrieval procedure: Calibration technique for microwave ovens
11. K-ras-2 topographic genotyping of pancreatic adenocarcinoma
12. Sporadic and thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2
13. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome
14. Primary small cell carcinoma of the pancreas
15. Classification of pancreatic cancer (nonendocrine)
16. Anaplastic carcinoma arising in ectopic pancreas located in the distal esophagus
17. Hypercalcemia in small cell carcinoma of the pancreas
18. Small cell carcinoma of the pancreas and biliary tract
19. Diagnostic features on images in primary small cell carcinoma of the pancreas
20. Small cell undifferentiated carcinoma of the pancreas. Report of a patient with tumor marker studies
21. Oat cell carcinoma of the pancreas with ectopic ACTH secretion
22. Primary tumors of the exocrine pancreas. Classification, overview, and recent contributions by immunohistochemistry and electron microscopy
23. Pleomorphic adenocarcinoma of the pancreas
24. Undifferentiated (anaplastic) carcinoma of the pancreas showing sarcomatous change and neoplastic cyst formation
25. Case report: Malignant giant cell tumour of the pancreas presenting as a large pancreatic cyst
26. Giant cell tumor of the pancreas arising in the ovarian-like stroma of a mucinous cystadenocarcinoma
27. Anaplastic carcinoma occurring in association with a mucinous cystic neoplasm of the pancreas
28. Pancreatic mucinous cystadenocarcinoma with a mural nodule of anaplastic carcinoma
29. Anaplastic carcinoma showing rhabdoid features combined with mucinous cystadenocarcinoma of the pancreas
30. Pancreatic mucinous cystadenocarcinoma with pseudosarcomatous mural nodules. A report of a case with immunohistochemical study
31. Giant cell carcinoma of the pancreas
32. Tumors of the pancreas with osteoclast-like and pleomorphic giant cells. An immunohistochemical and ploidy study
33. Osteoclastic" giant cell carcinoma of the pancreas. Report of a case with aspiration cytology
34. Giant cell tumor of the pancreas of mixed osteoclastic and pleomorphic cell type: Evidence for a histogenetic relationship and mesenchymal differentiation
35. Sarcomatoid carcinoma: An ultrastructural study with light microscopic and immunohistochemical correlation of 10 cases from various anatomic sites
36. The osteoclast-type giant cell tumor of the pancreas
37. Osteoclastic giant cell tumor of the pancreas. An immunohistological study and review of the literature
38. K-ras oncogene mutations suggest a common histogenetic origin for pleomorphic giant cell tumor of the pancreas, osteoclastoma of the pancreas and pancreatic duct adenocarcinoma
39. Undifferentiated carcinoma of the pancreas: Analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin
40. Hematogenous metastases of pancreatic ductal carcinoma
41. A case of pleomorphic carcinoma of the pancreas showing sequential histological change by immunohistochemical study
42. Fine-needle aspiration biopsy of pleomorphic (giant cell) carcinoma of the pancreas
43. Giant cell tumor ("osteoclastoma") of the pancreas: A tumor of epithelial origin
44. Cytokeratins and mucins as molecular markers of cell differentiation and neoplastic transformation in the exocrine pancreas
45. Carcinoma of the pancreas simulating giant cell tumor of bone. Electron-microscopic evidence of its acinar cell origin
46. Induction of unusual pancreatic neoplasms, with morphologic similarity to human tumors, and evidence for their ductal/ductular cell origin
47. Mixed pleomorphic-osteoclast-like tumor of the pancreas. Light microscopical, immunohistochemical, and molecular biological studies
48. Needle aspiration cytology, immunocytochemistry, and electron microscopic study of unusual pancreatic carcinoma with pleomorphic giant cells
49. Significance of giant cells in fine needle aspiration biopsies of benign and malignant lesions of the pancreas
50. An unusual epithelial pleomorphic giant cell tumour of the pancreas with osteoclast-type cells
51. Osteoclast-like giant cell tumour of the pancreas presenting as a pseudocyst-like lesion
52. Undifferentiated tumors: An immunohistochemical analysis on biopsies
53. Osteoclastic giant cell tumor of the pancreas. An immunohistochemical study
54. KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas
55. Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and periampullary region
56. Adenocarcinoma of the pancreas with osteoclast-like giant cells: A case report with immunocytochemistry
57. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma
58. Frequent K-ras mutations and absence of p53 mutations in mucin-producing tumors of the pancreas
59. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
60. K-ras mutation and pancreatic adenocarcinoma
61. Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen
62. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer
63. Ki-ras oncogene activation in preinvasive pancreatic cancer
64. Genetic basis of cancer of the pancreas: Diagnostic and therapeutic alterations
65. The cell cycle and regulation of cancer cell growth
66. Cancer cell cycles
67. Mutation of cell cycle regulations. Biological and clinical implications for human neoplasia
68. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
69. Kip1 protein: Prognostic implications in primary breast cancer
70. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
71. Cancer prognostics: Past, present and p27. Reduced expression of the p27 cell cycle inhibitor predicts poor cancer patient survival
72. Increased proteosome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
73. p27 expression and gastric carcinoma
74. Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer
75. Prognostic significance of molecular alterations in human pancreatic carcinoma. An immunohistological study
76. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer
77. p53 mutations in two patients with intraductal papillary adenoma of the pancreas
78. K-ras and p53 gene mutations in pancreatic cancer: Ductal and nonductal tumors progress through different genetic lesions
79. An immunohistochemical study of c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas
80. Sarcomatoid carcinoma of the pancreas presenting as gastric carcinoma: Clinicopathologic and ultrastructural findings
81. Survival in 1001 patients with carcinoma of the pancreas
82. Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies